Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chad Moretz, Lucie Sharpsten, Lindsay GS Bengtson, Eleena Koep, Lisa Le, Junliang Tong, Richard H Stanford, Beth Hahn & Riju Ray. (2019) Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1721-1737.
Read now
Read now
Christopher F. Bell, Anna D. Coutinho, Eileen Farrelly, Tasneem Lokhandwala & Pamela Landsman-Blumberg. (2018) Clinical and economic outcomes associated with the use of fluticasone propionate 250 mcg and salmeterol 50 mcg combination versus tiotropium bromide 18 mcg as initial maintenance treatment for chronic obstructive pulmonary disease in managed care. Journal of Medical Economics 21:6, pages 629-638.
Read now
Read now
Henry Covelli, Bonavuth Pek, Isabelle Schenkenberger, Catherine Scott-Wilson, Amanda Emmett & Courtney Crim. (2016) Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1-12.
Read now
Read now
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Funda Secik. (2016) Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2859-2867.
Read now
Read now
M. H. Roberts, M. E. Borrego, A. A. Kharat, P. L. Marshik & D. W. Mapel. (2016) Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 167-192.
Read now
Read now
Timothy E Albertson, Richart Harper, Susan Murin & Christian Sandrock. (2015) Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Preference and Adherence 9, pages 235-242.
Read now
Read now
Mayank Ajmera, Amit D Raval, Chan Shen & Usha Sambamoorthi. (2014) Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 339-348.
Read now
Read now
A. Ismaila, D. Corriveau, J. Vaillancourt, D. Parsons, A. Dalal, Z. Su & J.S. Sampalis. (2014) Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Current Medical Research and Opinion 30:7, pages 1427-1436.
Read now
Read now
Articles from other publishers (2)
Ramesh Chokhani, Abdul Razak Muttalif, Kirthi Gunasekera, Aniruddha Mukhopadhyay, Vaibhav Gaur & Jaideep Gogtay. (2021) Understanding Practice Patterns of COPD: A Survey of Physicians in Nepal, Sri Lanka and Malaysia. Pulmonary Therapy 7:1, pages 251-265.
Crossref
Crossref
Luís Midão, Anna Giardini, Enrica Menditto, Przemyslaw Kardas & Elísio Costa. 2018. Gerontology. Gerontology.